GPR84 and cancer: LY-237 and 6-octylaminouracil have been reported to act as an agonist at GPR84 which is currently in preclinical research.178,179 Given the dual role of GPR84 in cancer, it would be meaningful to explore its specific mechanisms in different types of cancer.